Ablexis LLC, of San Francisco, appointed Scott Greer chairman and named Richard Hoffman chief business officer...Bioheart Inc., of Sunrise, Fla., appointed Mike Tomas president, CEO and board member, replacing Karl Groth, who will retain his position as chairman...Illumina Inc., of San Diego, appointed Nicholas J. Naclerio senior vice president of corporate development
Algeta ASA, of Oslo, Norway, elected Judith Hemberger and Kapil Dhingra to its board of directors...CMDBioscience, of Orange, Conn., appointed Erick Suchanek and Bernhardt Trout to its scientific advisory board...Medivir AB, of Huddinge, Sweden, appointed Håkan Wallin vice president of corporate development
Xcellerex Inc., of Marlborough, Mass., appointed Guy Broadbent president and CEO...The firm's former president and CEO, Joseph Zakrzewski, will remain on with the company as chairman of the board...Silicon Kinetics Inc., of San Diego, named Rick Brown and Eric Topol to its board
Prior to joining VaxInnate, Hofstaetter was senior vice president of corporate business development at Wyeth, where he also headed global business development for the company's pharmaceutical division
team, with Greg Hamilton as chief operating officer and chief financial officer...Suzanne McDonald head of managed markets and government affairs...operations and also appointed Jon Terrett vice president of oncology at its San Jose, Calif
Dyax Corp., of Cambridge, Mass., appointed Ivana Magovcevic-Liebisch executive vice president of corporate development and general counsel...Neovacs, of Paris, named Piers Whitehead vice president of corporate development
BioWa Inc., of Princeton, N.J., appointed Marc Silver vice president of corporate development...Cellular Dynamics International, of Madison, Wis., appointed Leroy Hood and George Church to its scientific advisory board
Lexicon Pharmaceuticals Inc., of The Woodlands, Texas, appointed Ajay Bansal executive vice president of corporate development and chief financial officer...MDRNA Inc., of Bothell, Wash., appointed Beverly L. Davidson and Carl Novina to its scientific advisory board...Orexigen Therapeutics Inc., of San Diego, named Jay Hagan senior vice president of corporate development and strategy
and Steve Neben senior director of project and alliance management...Oxigene Inc., of Waltham, Mass., named Nicole Onetto and Eric K. Rowinsky to the board of its subsidiary Symphony ViDA Inc
BiPar Sciences Inc., of Brisbane, Calif., named Sunil Patel vice president of corporate development and marketing and appointed Adrienne Weil legal counsel...It formed its scientific advisory board with the appointments of Dennis Brown, Xandra Breakefield and Richard L. Edelson, and also appointed Johan Skog director of genetics research
Onyx Pharmaceuticals Inc., of Emeryville, Calif., appointed Juergen Lasowski senior vice president of corporate development...Targanta Therapeutics Corp., of Cambridge, Mass., appointed Stéphane Bancel and Rosemary A. Crane to its board
Arcxis Biotechnologies, of Pleasanton, Calif., named Christine Meda president and CEO...MicroIslet Inc., of San Diego, appointed Brian D. Conn vice president of corporate finance and chief financial officer
Regulus Therapeutics LLC, of Cambridge, Mass., appointed Garry Menzel executive vice president of corporate development and finance...TheraGenetics Ltd., of Cambridge, Mass., and London, appointed Susan E. Bromley global head of R&D and named Kenneth B. Milne UK director of R&D
Ablexis LLC, of San Francisco, appointed Scott Greer chairman and named Richard Hoffman chief business officer...Bioheart Inc., of Sunrise, Fla., appointed Mike Tomas president, CEO and board member, replacing Karl Groth, who will retain his position as chairman...Illumina Inc., of San Diego, appointed Nicholas J. Naclerio senior vice president of corporate development